UPS extends pharma network

UPS customers can now ship biological substances, dangerous goods in excepted quantities and shipments using dry ice to more than 20 additional international destinations.
The US-based global express and logistics’ operator says that the expansion is a direct response to a growing demand from biopharmaceutical manufacturers, diagnostics companies, laboratories and distributors.  
“The UPS global transportation network has been enhanced to move biological specimens to and from more than 50 countries around the world,” said John Menna, UPS vice president of global strategy, healthcare logistics.
“The expanded programme was guided by our customers to include the locations that are most important to them.”
UPS is now able to pick up and deliver packages under regulation UN3373 (Biologic Substances, Category B, Diagnostic Specimen and Clinical Specimen) as well as UN1845 (Carbon Dioxide, solid or dry ice) in Australia, Bulgaria, Croatia, Estonia, India, Indonesia, Israel, Latvia, Lithuania, New Zealand, Panama, Romania, Russia, Saudi Arabia, Slovakia, Slovenia, South Africa, Taiwan, Turkey and Ukraine.
UN3373 and UN1845 are guidelines issued by the International Air Transport Association (IATA) to regulate the safe transportation of goods using air transportation modes. 

Share this story

Related Topics

Latest bellyhold airline news

IAG Cargo resumes flights to South Korea

By Rachelle Harry

IAG Cargo has resumed its direct service from London Heathrow to Seoul-Incheon in South Korea after having suspended the route…

Read More

Share this story

Virgin Atlantic Cargo launches new pharma service as it prepares for vaccine

By Damian Brett

Virgin Atlantic Cargo has added a new pharma service ahead of the launch of a new Covid-19 vaccine. The airline…

Read More

Share this story

Swiss hits 1,000 cargo-only flights

Since the beginning of the coronavirus crisis in March, Swiss International Air Lines (Swiss) has operated more than 1,000 cargo-only…

Read More

Share this story